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Abstract
AIM: To investigate whether caspase-1 activation/in-
tracellular processing of pro-interleukin-1β (pro-IL-1β) 
and extracellular release of mature IL-1β from activated 
monocytes are separable events. 
METHODS: All experiments were performed on fresh 
or overnight cultured human peripheral blood mono-
cytes (PBMCs) that were isolated from healthy donors. 
PBMCs were activated by lipopolysaccharide (LPS) 
stimulation before being treated with Adenosine tri-
phosphate (ATP, 1 mmol/L), human α-defensin-5 (HD-5, 
50 μg/mL), and/or nigericin (Nig, 30 μmol/L). For each 
experiment, the culture supernatants were collected 
separately from the cells. Cell lysates and supernatants 
were both subject to immunoprecipitation with anti-IL-
1β antibodies followed by western blot analysis with 
anti-caspase-1 and anti-IL-1β antibodies.
RESULTS: We found that pro-IL-1β was processed 
to mature IL-1β in LPS-activated fresh and overnight 
cultured human monocytes in response to ATP stimu-
lation. In the presence of HD-5, this release of IL-1β, 
but not the processing of pro-IL-1β to IL-1β, was com-
pletely inhibited. Similarly, in the presence of HD-5, the 
release of IL-1β, but not the processing of IL-1β, was 
significantly inhibited from LPS-activated monocytes 
stimulated with Nig. Finally, we treated LPS-activated 
monocytes with ATP and Nig and collected the super-
natants. We found that both ATP and Nig stimulation 
could activate and release cleaved caspase-1 from the 
monocytes. Interestingly, and contrary to IL-1β pro-
cessing and release, caspase-1 cleavage and release 
was not blocked by HD-5. All images are representative 
of three independent experiments.
CONCLUSION: These data suggest that caspase-1 
activation/processing of pro-IL-1β by caspase-1 and the 
release of mature IL-1β from human monocytes are 
distinct and separable events.
© 2013 Baishideng. All rights reserved.
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Core tip: Activated macrophages release large amounts 
of interleukin-1β (IL-1β) and macrophages deficient in 
caspase-1 expression have undetectable IL-1β secretion. 
This suggests that IL-1β release and caspase-1 activa-
tion are closely related events. We found that human 
α-defensin 5 (HD-5) inhibited the release of IL-1β, but 
not the processing of pro-IL-1β to IL-1β in lipopolysac-
charide-activated monocytes stimulated with Adenosine 
triphosphate or nigericin. Different from IL-1β processing 
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and release, the activation and release of caspase-1 from 
stimulated monocytes was not blocked by HD-5. These 
data suggest that caspase-1 activation/processing of pro-
IL-1β by caspase-1 and the release of mature IL-1β from 
human monocytes are distinct and separable events.
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INTRODUCTION
Interleukin-1β (IL-1β) is an important acute response 
factor of  host defense against microbial infections and a 
key mediator of  inflammation in multiple organs[1,2]. Viral 
and bacterial pathogens trigger inflammasome formation 
and subsequent caspase-1 activation and IL-1β matura-
tion[3]. IL-1β is synthesized as a biologically inactive 31 
kDa pro-IL-1β polypeptide and must be post-transla-
tionally processed by caspase-1 to generate the mature 17 
kDa pro-inflammatory cytokine IL-1β[4]. Overproduction 
of  IL-1β is associated with multiple autoimmune diseases 
and septic shock and animals deficient in IL-1β are highly 
susceptible to microbial infections[5,6].
Activated monocytes and macrophages rapidly release 
large amounts of  mature IL-1β and inflammasome compo-
nents including caspase-1[7]; macrophages deficient in cas-
pase-1 expression have impaired processing of  pro-IL-1β 
and undetectable IL-1β secretion[8]. This suggests that IL-
1β release and caspase-1 activation are closely related events. 
Because most known inhibitors of  IL-1β production block 
caspase-1 activation, previous studies are not able to deter-
mine whether caspase-1 activation/pro-IL-1β processing 
and IL-1β release are separate or linked processes. We have 
previously demonstrated that human defensin peptide hu-
man α-defensin-5 (HD-5) can block the release of  IL-1β, 
but not tumor necrosis factor-α (TNF-α), from lipopoly-
saccharide (LPS)-activated human monocytes stimulated 
with Adenosine triphosphate (ATP)[9]. Here, using HD-5 
as a molecular tool, we explored whether IL-1β release is 
an indivisible process from caspase-1 activation/pro-IL-1β 
processing in human monocytes. 
MATERIALS AND METHODS
Human HD-5
Synthetic human defensin HD-5 was prepared by t-Boc 
solid-phase synthesis as described previously[9]. All peptides 
were folded and purified to homogeneity by reversed-phase-
high-performance liquid chromatography and their molecular 
weights verified by electrospray ionization mass spectrometry.
Peripheral blood monocyte isolation 
Peripheral blood monocytes (PBMC) from healthy adult 
donors were prepared as described previously[9]. Briefly, 
blood was diluted with RPMI 1640, overlaid on lympho-
cyte separation medium (Mediatech), and centrifuged 
at 400 × g for 35 min. The mononuclear cell layer was 
washed with PBS and centrifuged at 250 × g for 10 min. 
The cells were then resuspended in 25 mL of  PBS plus 
citrate solution and overlaid on Percoll (GE Healthcare) 
prediluted 9/1 with 1.5 mol/L NaCl. After a 35-min cen-
trifugation at 400 × g, the PBMC were washed with PBS 
again. Cells were counted using trypan blue exclusion and 
cells were resuspended in monocyte medium [RPMI 1640, 
5%FBS, 20 mmol/L HEPES (pH 7.3), 1%streptomycin/
penicillin] and incubated at 37 ℃ for 2 h to allow for ad-
herence, after which medium supernatants were discarded. 
Attached cells were rinsed twice with monocyte medium 
and used immediately or incubated in monocyte medium 
overnight at 37 ℃ in a 5%CO2 environment. 
IL-1β  posttranslational processing and release assay 
Fresh or overnight cultured PBMCs were treated with 20 
ng/mL LPS for 2 h at 37 ℃. In some experiments, the 
media was removed then replaced with RPMI (without 
Met, Cys, or Glu), + 1% FBS + 25 mmol/L HEPES pH 
7.4 + 300 mg/L Glutamine + 83 μCi/mL 35S-Met/Cys 
and incubated at 37 ℃ for 1 h. Cells were then rinsed 
and media was replaced with RPMI (+ Glu). Adenos-
ine triphosphate (ATP, 1 mmol/L), HD-5 (50 μg/mL), 
and/or nigericin (Nig, 30 μmol/L) was added to culture 
media and incubated at 37 ℃ for 1.5 h. The supernatants 
were collected, 1%Triton X-100 and protease inhibitor 
cocktail (Sigma-Aldrich, St. Louis, MO, United States) 
added, then spun down. Cells were lysed in 500 μL lysis 
buffer (25 nmol/L HEPES pH 7.4 + 150 mmol/L NaCl 
+ 0.1%Triton X-100 + Protease Inhibitor cocktail) then 
spun down. Cell lysates and supernatants were subject to 
IL-1β immunoprecipitation and western blot analysis of  
caspase-1 as described previously[9]. Results shown are a 
representative from three independent experiments.
Statistical analysis
All experiments were repeated 3 times to ensure repro-
ducibility. Image J software (NIH) was used to quantitate 
protein bands. Proteins bands between two different 
treatment groups were considered statistically significant 
when P < 0.05, by t-test analysis.
RESULTS
HD-5 blocks the release of IL-1β  from both freshly 
isolated and overnight cultured monocytes
Our previous studies have shown that HD-5 can block 
the release of  pro-IL-1β and mature IL-1β from ATP 
stimulated human monocytes that were cultured overnight 
prior to LPS exposure[9]. Since culturing monocytes in 
vitro can lead to further differentiation into macrophage-
like cells[10,11], we determined whether the subcultured 
monocytes behaved similarly to freshly isolated cells. As 
shown in Figure 1 (upper panel) the extracellular release 
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of  mature IL-1β from both freshly isolated and overnight 
cultured monocytes was blocked by HD-5. Interestingly, 
we also observed that freshly isolated monocytes had 
enhanced intracellular processing of  pro-IL-1β to IL-1β 
(Figure 1, lower panel, lanes 1-2 vs 3-4) suggesting that in-
creased time in culture can decrease the ability of  mono-
cytes to process IL-1β. Most importantly, it was found 
that the intracellular processing of  pro-IL-1β to mature 
IL-1β was not inhibited by HD-5 as evidenced by the 
presence of  intracellular mature IL-1β in cell lysates from 
monocytes treated with HD-5 (Figure 1, lower panel).
HD-5 treatment significantly blocks IL-1β  release from 
monocytes stimulated with Nig
To determine whether the ability of  HD-5 to block IL-
1β release in overnight-cultured, LPS-activated monocytes 
was specific to ATP stimulation, we treated LPS-activated 
monocytes with ATP or Nig. Similar to ATP, Nig is a 
microbial toxin that acts as an inflammasome inducer, 
leading to caspase-1 maturation and IL-1β processing and 
release[12,13]. We found that, similar to its effect on ATP-
mediated IL-1β release, HD-5 treatment was also able to 
significantly block IL-1β release from monocytes stimulat-
ed with Nig (Figure 2, upper panel). Furthermore, HD-5 
did not block Nig-induced intracellular processing of  pro-
IL-1β to mature IL-1β as indicated by the presence of  
mature IL-1β in the cell lysate (Figure 2, lower panel).
ATP and Nig-mediated caspase-1 activation and 
extracellular release from LPS-activated monocytes is 
not affected by HD-5
Caspase-1 activation has been implicated in both the 
processing and release of  IL-1β[14,15]. Because our current 
studies have shown that HD-5 selectively blocked the re-
lease but not the processing of  pro-IL-1β to mature IL-
1β, it is important to know whether HD-5 has any effect 
on caspase-1 activation and release. As shown in Figure 3, 
ATP/Nig-mediated caspase-1 activation and extracellular 
release from LPS-activated monocytes were not affected 
by HD-5. This observation is consistent with the finding 
that HD-5 did not block the intracellular processing of  
pro-IL-1β to IL-1β (Figures 1 and 2).
DISCUSSION
Current research suggests that once caspase-1 becomes 
active it leads to both the processing and release of  IL-
1β[16-18]. Although the processing and release of  IL-1β 
are rapid and probably concurrent events, it has been 
suggested previously that the cleavage of  pro-IL-1β and 
release of  mature IL-1β are likely independent of  each 
other[19]. However, this speculation remains hypothetical 
because, due to the technical limitations, the presence of  
mature IL-1β inside LPS-primed, ATP-stimulated mono-
cytes have not been documented prior to this report. 
Here, under certain conditions we have clearly shown 
that IL-1β release but not its processing from pro-IL-1β 
by caspase-1 in ATP/Nig-stimulated monocytes can be 
blocked by HD-5. To our knowledge, this report provides 
the first direct evidence that the processing of  pro-IL-1β 
to mature IL-1β and extracellular release of  mature IL-
1β are two divisible events in human monocytes. 
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Figure 1  Human α-defensin 5 blocks the release from but not the pro-
cessing of interleukin-1β in fresh and overnight cultured human mono-
cytes. Freshly isolated or overnight cultured human monocytes were primed 
with lipopolysaccharide (LPS) (20 ng/mL) for 2 h before being labeled with 
35S-methionine/cysteine for 1 h and then washed and treated with Adenosine 
triphosphate (ATP, 1 mmol/L) and/or human α-defensin 5 (HD-5) (50 μg/mL) for 
another 1.5 h. Media and cell-associated fractions were harvested separately. 
Interleukin-1β (IL-1β) was recovered from each by immunoprecipitation with 
anti-hIL-1β antibodies (1:1000) that recognize both the pro-IL-1β (31 kDa) and 
mature IL-1β (17 kDa) proteins. The resulting immunoprecipitates were ana-
lyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and autora-
diography. Images are representative from three independent experiments.
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Figure 2 Human α-defensin 5 blocks interleukin-1β release from mono-
cytes stimulated with Adenosine triphosphate or nigericin. Overnight-
cultured, lipopolysaccharide (LPS)-activated, 35S-Met/cys-labeled human 
monocytes were treated with Adenosine triphosphate (1 mmol/L) or nigericin 
(Nig) (30 μmol/L) in the presence or absence of human α-defensin 5 (HD-5) 
(50 μg/mL) for 1.5 h. Media and cell-associated fractions were harvested sepa-
rately. Interleukin-1β (IL-1β) was recovered from each by immunoprecipitation 
and resulting immunoprecipitates were analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and autoradiography. Images are represen-
tative from three independent experiments.
Our results also indicate that the majority of  pro-IL-
1β is processed intracellularly by activated caspase-1 in 
freshly isolated monocytes (Figure 1A). This observation 
is consistent with the report that human blood mono-
cytes release processed IL-1β after a one-time stimula-
tion with toll-like receptor 4 ligands due to the resulting 
constitutively activated caspase-1[16]. Furthermore, be-
cause the release of  IL-1β, but not the externalization 
of  caspase-1 was affected by HD-5, our studies suggest 
that IL-1β seems to be released directly to the extracel-
lular environment without the involvement of  caspase-1 
inflammasome. 
The mechanisms by which pro-IL-1β and mature IL-
1β are released from cytokine producing cells have been 
an intriguing and unsolved question of  IL-1β biology 
for decades. Known activators of  caspase-1 and IL-1β 
release include ATP, adjuvants, and various microbial mol-
ecules[20]. Using different experimental systems, studies on 
ATP-induced IL-1β maturation have posited four differ-
ent and conflicting models of  IL-1β secretion, including 
secretory lysosome exocytosis[21,22], microvesicle shed-
ding[23-25], direct transport across the plasma membrane[26], 
and exocytosis of  exosome-containing multivesicular 
bodies[7]. The multiple models of  IL-1β secretion reflect 
the confusion in this area. It is true that although ATP-
induced caspase-1 activation is followed by the processing 
of  pro-IL-1β to IL-1β in the cytosol and secretion of  IL-
1β, other protein release mechanisms, such as externaliza-
tion of  caspase-1, secretory lysosomes and microvesicle 
shedding, do occur. However, externalization of  caspase-1 
and other inflammasome components, secretory lyso-
somes and microvesicle shedding may be cell-type specific 
processes after ATP stimulation and may not be involved 
in IL-1β secretion from monocytes. Here, we provide 
direct evidence that IL-1β secretion is a separable process 
from inflammasome activation/caspase-1 externalization 
and IL-1β processing in human monocytes. Inflamma-
some activation and caspase-1 activity are required but not 
sufficient for the release of  IL-1β.
Taken together, our studies clearly demonstrated 
that intracellular processing of  pro-IL-1β to mature IL-
1β and the externalization of  mature IL-1β are divisible 
events in human monocytes. Although the molecular 
mechanisms by which HD-5 blocks the release of  mature 
IL-1β has yet to be revealed in future studies, a better un-
derstanding of  IL-1β processing and release may lead to 
the discovery of  novel molecular targets for IL-1β block-
ade and the development of  new therapeutic approaches 




Interleukin-1β (IL-1β) is secreted by monocytes and macrophages and is an 
important acute response factor of host defense against microbial infections. IL-
1β is synthesized as a biologically inactive 31 kDa pro-IL-1β polypeptide and 
must be post-translationally processed by caspase-1 to generate the mature 17 
kDa IL-1β that is released into the extracellular space. 
Research frontiers
Macrophages deficient in caspase-1 expression have undetectable IL-1β secre-
tion. This suggests that IL-1β release and caspase-1 activation are closely related 
events. Because most known inhibitors of IL-1β production block caspase-1 
activation, previous studies are not able to determine whether caspase-1 activa-
tion/pro-IL-1β processing and IL-1β release are separate or linked processes. 
This report shows that processing of pro-IL-1β by caspase-1 and the release of 
mature IL-1β from human monocytes are distinct and separable events.
Innovations and breakthroughs
Recent reports suggest IL-1β secretion involves the formation of the inflam-
masome, leading to the cleavage and activation of caspase-1, which in turn 
proteolytically processes pro-IL-1β. Biologically active IL-1β is subsequently 
secreted by the cell. Here authors propose that IL-1β secretion involves a more 
complex regulatory mechanism.
Applications
Standard therapy for patients with autoimmune diseases or lymphomas 
involves blocking IL-1β activity. By knowing how IL-1β is processed and re-
leased, this study may lead to the development of novel therapeutics that can 
block IL-1β release and prevent or enhance treatment for these debilitating pro-
inflammatory disorders.
Terminology
The inflammasome is a multi-protein complex responsible for the activation of 
caspase-1, an enzyme that cleaves and activates downsteam targets such as 
IL-1β. IL-1β is a pro-inflammatory cytokine secreted by immune cells to aid in 
the defense of microbial infection. Human α-defensin 5 (HD-5) is an anti-micro-
bial peptide that normally functions by binding to the microbial cell membrane to 
form a lethal pore.
Peer review
The authors examined the ability of HD-5 to block the release, but not the acti-
vation, of IL-1β from Adenosine triphosphate and nigericin stimulation human 
monocytes. It revealed that while HD-5 can block IL-1β release, caspase-1 
activation is not affected. The results are interesting and may represent a new 
molecular mechanism in IL-1β secretion.
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